Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

计划入组 224 人 · 首次发布于 2025 年 4 月 27 日

Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

计划入组 47 人 · 首次发布于 2022 年 10 月 10 日

Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS)

计划入组 41 人 · 首次发布于 2022 年 2 月 9 日

allogeneic CAR T-cell therapy

bispecific antibody (follicular lymphoma)

Anti-CD5 CAR T-cell therapy

T-Knife GmbH

Germany

PH & T SpA

Italy

T-Balance Therapeutics GmbH

Germany

Treeline and Roche Collaborate on Phase 1 Trial of BCL6 Degrader TLN-121 Combined with CD20×CD3 Bispecifics in B-Cell Lymphomas

CAR T-Cell Therapy AUTO4 Shows Promise in Treating Peripheral T-Cell Lymphoma

Duvelisib Shows Promising Results in Relapsed/Refractory Peripheral T-Cell Lymphoma Phase 2 Trial